ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,937.34
      -0.21%
      US Tech 100
      20,523.20
      0.00%
      Dow Jones
      43,153.13
      -0.16%
      Brent Oil
      80.785
      0.34%
      Bitcoin
      102,080.86
      2.07%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Oric Pharmaceuticals Inc (ORIC) Quote

      Oric Pharmaceuticals Inc

      Oric Pharmaceuticals Inc (ORIC)

      NASDAQ
      10.04
      0.00
      (0.00%)
      Closed January 17 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      10.04
      Bid
      9.76
      Ask
      10.67
      Volume
      -
      0.00 Day's Range 0.00
      6.33 52 Week Range 16.65
      Market Cap
      708.492M
      Previous Close
      10.04
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      468,931
      Shares Outstanding
      70,566,950
      Dividend Yield
      -
      PE Ratio
      -7.04
      Earnings Per Share (EPS)
      -1.43
      Revenue
      -
      Net Profit
      -100.7M

      About Oric Pharmaceuticals Inc

      ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company h... ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.oricpharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Oric Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ORIC. The last closing price for Oric Pharmaceuticals was $10.04. Over the last year, Oric Pharmaceuticals shares have traded in a share price range of $ 6.33 to $ 16.65.

      Oric Pharmaceuticals currently has 70,566,950 shares outstanding. The market capitalization of Oric Pharmaceuticals is $708.49 million. Oric Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.04.

      Ask ADVFN Intelligence (AI)

      ORIC Latest News

      More News

      Form 8-K - Current report

      January 13 2025
      Edgar (US Regulatory)

      ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones

      Announces encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with apalutamide in patients with mCRPC Entered into clinical trial collaboration...

      January 13 2025
      GlobeNewswire Inc.

      ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

      January 13 2025
      GlobeNewswire Inc.

      ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

      January 06 2025
      GlobeNewswire Inc.

      ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

      January 03 2025
      GlobeNewswire Inc.

      ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

      SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address...

      November 25 2024
      GlobeNewswire Inc.

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 12 2024
      Edgar (US Regulatory)

      ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

      Presented preclinical data further supporting the potential best-in-class profile of ORIC-114 to treat EGFR exon 20 insertions and other atypical mutations at the EORTC-NCI-AACR Conference...

      November 12 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.9423.9506172848.111.157.868662009.74038356CS
      42.48532.89212442097.55511.157.446259339.06484274CS
      121.618.95734597168.4411.157.414689319.15596787CS
      26-1.17-10.437109723511.2112.837.414587999.61551936CS
      521.7220.67307692318.3216.656.3351612910.13704912CS
      156-2.67-21.007081038612.7116.652.364544397.43341318CS
      260-15.96-61.38461538462640.812.3637118211.45181416CS

      ORIC - Frequently Asked Questions (FAQ)

      What is the current Oric Pharmaceuticals share price?
      The current share price of Oric Pharmaceuticals is $ 10.04
      How many Oric Pharmaceuticals shares are in issue?
      Oric Pharmaceuticals has 70,566,950 shares in issue
      What is the market cap of Oric Pharmaceuticals?
      The market capitalisation of Oric Pharmaceuticals is USD 708.49M
      What is the 1 year trading range for Oric Pharmaceuticals share price?
      Oric Pharmaceuticals has traded in the range of $ 6.33 to $ 16.65 during the past year
      What is the PE ratio of Oric Pharmaceuticals?
      The price to earnings ratio of Oric Pharmaceuticals is -7.04
      What is the reporting currency for Oric Pharmaceuticals?
      Oric Pharmaceuticals reports financial results in USD
      What is the latest annual profit for Oric Pharmaceuticals?
      The latest annual profit of Oric Pharmaceuticals is USD -100.7M
      What is the registered address of Oric Pharmaceuticals?
      The registered address for Oric Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Oric Pharmaceuticals website address?
      The website address for Oric Pharmaceuticals is www.oricpharma.com
      Which industry sector does Oric Pharmaceuticals operate in?
      Oric Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 18.29
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 72.30
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 3.13
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.99
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 18.29
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 72.30
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 3.13
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.99
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 18.29
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 72.30
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 3.13
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.99
      (0.00%)
      		0

      ORIC Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 6 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 6 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 8 months ago
      ORIC 10Q due 5/6
      👍️0
      Monksdream Monksdream 8 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 10 months ago
      ORIC 10Q due 3/16
      👍️0
      Monksdream Monksdream 10 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 10 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 11 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 11 months ago
      ORIC new 52 weewk high
      👍️0
      Monksdream Monksdream 12 months ago
      ORIC new 52 week high
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      $ORIC LOOKS LIKE $6 COMING
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: Tapped $5.40....... still got steam

      It ain't over yet





      GO $ORIC
      👍️0
      DH112 DH112 2 years ago
      Today is green fields
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

      https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: 5.25 now........................... lets get to $10

      I know you can do it babyyyyyyyyyyyyyyyyy


      GO $ORIC
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC : Now at 4.90

      YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

      Me likes it


      GO $ORIC
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

      The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

      The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

      The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


      Write to Dean Seal at dean.seal@wsj.com


      (END) Dow Jones Newswires

      December 22, 2022 07:25 ET (12:25 GMT)
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

      Letssssssss goooooooooooooooooo.


      Added 5k shares here at 4.30

      Great NEWS


      https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

      GO $ORIC
      👍️0

      Your Recent History

      NASDAQ
      ORIC
      Oric Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads